Most Recent
A judge has found he has power to order that opt out notices be sent to a limited number of Boral shareholders eligible to join two class actions that faced off last month in a class action beauty parade.
Hoping to avoid a lengthy trial like the 89-day hearing in the pelvic mesh class action against Johnson & Johnson's Ethicon, a judge has suggested splitting up a class action hearing over TFS Manufacturing and IVS pelvic mesh products to focus on the question of the devices' safety and efficacy first.
A $138 million class action settlement with IAG over alleged junk insurance will go ahead after a judge found he was "bereft" of power to vary his prior approval judgment and include late opt out bids by group members that threatened to derail the agreement last month.
News Corp and journalist Annette Sharp will have to pay the legal costs of Sydney lawyer Christopher Murphy who won a $110,000 judgment in his defamation case against the publisher, despite the lawyer rejecting an $120,000 offer to settle the case.
The half-brother and manager of NBA star Ben Simmons has filed defamation proceedings against his half-sister over a barrage of tweets accusing him of sexually molesting her when she was a child.
A judge has urged the parties in two pelvic mesh class actions against Boston Scientific to come up with a "pragmatic solution" to the competing proceedings filed in the Federal and NSW Supreme courts.
High profile criminal lawyer Christopher Murphy has been awarded a $110,000 judgment in his defamation case over a "gossipy and intrusive" Daily Telegraph article which a judge found had damaged the lawyer's professional reputation.
Phi Finney McDonald will amend its funding agreement with Therium in a shareholder class action against Boral after a judge found that an irrevocable opt out provision placed the law firm in a "manifest position of conflict".
A Johnson & Johnson unit wants the High Court to review the Full Federal Court's rejection of its challenge to a landmark class action ruling that found the company's pelvic mesh implants were defective and that it failed to adequately warn about their risks.
Johnson & Johnson's Ethicon unit is facing a second class action over its allegedly defective pelvic mesh products, following a landmark ruling that found the drug company did not adequately warn about the devices' risks.